
Quick answer
Hepatocellular carcinoma is the most common primary liver cancer, usually arising in damaged or cirrhotic liver tissue and managed according to the tumor’s stage and the liver’s function. At Acibadem in Turkey, evaluation typically combines imaging, blood tests, and pathology when needed, and treatment may include surgery, liver-directed therapies, systemic medicines, or liver transplantation within a multidisciplinary care plan.
Overview
Hepatocellular carcinoma is the most common type of primary liver cancer, meaning it begins in the liver. The liver is an important organ that helps process nutrients, filter harmful substances from the blood, produce bile for digestion, and support blood clotting. Hepatocellular carcinoma often develops in people who already have long-term liver disease, especially scarring of the liver known as cirrhosis.
This condition can be complex because liver cancer may affect both the tumor itself and the remaining healthy liver tissue. Treatment planning usually depends on the size and number of tumors, whether the cancer has spread, how well the liver is working, and the person’s overall health. Care is often provided by a multidisciplinary team that may include specialists in oncology, liver disease, surgery, interventional radiology, imaging, and supportive care.
Symptoms
Hepatocellular carcinoma may not cause noticeable symptoms in its early stages. In some people, it is found during routine monitoring for chronic liver disease. When symptoms do occur, they can be vague and may overlap with other liver conditions.
- Unexplained weight loss or loss of appetite
- Feeling unusually tired or weak
- Pain, discomfort, or a feeling of fullness in the upper right side of the abdomen
- Swelling or bloating of the abdomen
- Nausea or feeling full after small meals
- Yellowing of the skin or eyes, known as jaundice
- Dark urine or pale stools
- Easy bruising or bleeding
- Itching of the skin
- Worsening of previously stable liver disease
These symptoms do not always mean cancer is present, but they should be assessed by a healthcare professional, especially in people with known liver disease.
Causes and Risk Factors
Hepatocellular carcinoma usually develops after long-term irritation and damage to liver cells. Over time, repeated injury and repair can lead to scarring, abnormal cell changes, and, in some cases, cancer.
Common risk factors include:
- Chronic infection with hepatitis B or hepatitis C
- Cirrhosis from any cause
- Long-term heavy alcohol use
- Fatty liver disease related to metabolic conditions such as obesity or diabetes
- Inherited or chronic liver conditions that cause ongoing liver damage
- Exposure to certain toxins that can damage the liver
- Family history of liver cancer in some cases
Having a risk factor does not mean a person will develop hepatocellular carcinoma, and some people with the condition may not have obvious risk factors. However, people with chronic liver disease may be advised to have regular monitoring so that liver changes can be detected earlier.
Diagnosis
Diagnosis begins with a medical history, physical examination, and review of risk factors such as viral hepatitis, cirrhosis, alcohol use, and metabolic health. Blood tests may be used to assess liver function, blood clotting, and general health. Some tests may also look for markers that can be associated with liver cancer, although these results cannot confirm the condition by themselves.
Imaging is central to evaluating suspected hepatocellular carcinoma. Ultrasound, computed tomography, or magnetic resonance imaging may be used to look at the liver in detail. These scans can help identify the number, size, and location of liver lesions and whether blood vessels or nearby structures are involved.
In some cases, imaging findings in a person with cirrhosis or chronic liver disease may strongly suggest hepatocellular carcinoma. In other situations, a biopsy may be recommended. A biopsy involves taking a small sample of tissue for examination under a microscope. The decision to perform a biopsy depends on the person’s condition, imaging results, and potential risks.
If hepatocellular carcinoma is confirmed, further assessment may be needed to understand the stage of the disease and the function of the remaining liver. This information helps guide treatment planning.
Treatment Options
Treatment for hepatocellular carcinoma is individualized. The most suitable approach depends on the tumor characteristics, liver function, general health, and patient preferences. The goal may be to remove or destroy the tumor, control its growth, reduce symptoms, or support quality of life.
Possible treatment options include:
- Surgery to remove part of the liver when the tumor is limited and liver function is sufficient
- Liver transplantation in selected patients when both the cancer and underlying liver disease meet specific criteria
- Local ablation, which uses heat, cold, or other methods to destroy tumor tissue
- Interventional radiology procedures that deliver treatment directly to the tumor through blood vessels
- Radiation-based approaches in selected situations
- Systemic therapy, which treats cancer throughout the body and may be used when surgery or local treatments are not suitable
- Supportive and palliative care to help manage symptoms, nutrition, pain, fatigue, and emotional wellbeing
Because liver function is an important part of treatment safety, doctors carefully balance cancer control with protecting the remaining liver. Patients may also receive care for underlying liver disease, such as management of viral hepatitis, cirrhosis complications, or metabolic risk factors.
When to See a Doctor
Medical advice should be sought if a person develops persistent abdominal pain, unexplained weight loss, jaundice, swelling of the abdomen, unusual bleeding or bruising, or a sudden worsening of known liver disease. People with chronic hepatitis, cirrhosis, or other long-term liver conditions should follow their doctor’s recommendations for regular monitoring, even if they feel well.
Urgent medical attention is needed for severe abdominal pain, confusion, vomiting blood, black stools, severe weakness, or rapidly increasing abdominal swelling. These signs may indicate serious liver-related complications and require prompt assessment.
Anyone concerned about hepatocellular carcinoma or their personal liver cancer risk should discuss it with a qualified healthcare professional. Early evaluation can help clarify the cause of symptoms and support timely, appropriate care.
Treatments for This Condition
Doctors Who Treat This Condition

Prof. Dr. Banu Atalar
Radiation Oncology
Prof. Dr. Bünyamin Kaplan
Radiation Oncology
Prof. Dr. Enis Özyar
Radiation Oncology
Prof. Dr. Evrim Kadriye Tezcanlı
Radiation Oncology
Prof. Dr. Fulya Ağaoğlu
Radiation Oncology
Prof. Dr. Gamze Uğurluer Sümer
Radiation Oncology
Prof. Dr. H. Armağan Arıcan
Radiation Oncology
Prof. Dr. Işık Aslay
Radiation Oncology
Prof. Dr. Lütfi Özkan
Radiation Oncology
Prof. Dr. Mehmet Ufuk Abacıoğlu
Radiation Oncology
Prof. Dr. Meltem Serin
Radiation Oncology
